Trial Profile
Effectiveness of simeprevir-based triple therapy for patients with telaprevir failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 13 Jul 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 16 Jan 2015 New trial record